Schedule 13G ownership disclosure

Benitec Biopharma LTD/ADR

Security class unavailable · CUSIP: 082053307

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,881,443
Percent of class
3.9100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-17-000027
Form type
SC 13G/A
Filer
Benitec Biopharma LTD/ADR
CIK
CIK 1552795
Filed
Jan 09, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub